SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/12/23 FSD Pharma Inc. 6-K 5/12/23 2:21K Business Wire/FA |
Document/Exhibit Description Pages Size 1: 6-K Fsd Pharma Inc. 6-K HTML 10K 2: EX-99.1 Miscellaneous Exhibit HTML 12K
|
FSD Pharma Inc.
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
Date: May 12, 2023
|
By:
|
/s/ Nathan Coyle
|
|
|
|
Nathan Coyle, Chief Financial Officer
|
|
Exhibit
|
Description
|
|
|
Exhibit
99.1 |
This ‘6-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 5/12/23 | None on these Dates | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/20/24 FSD Pharma Inc. 424B5 2/16/24 1:863K RDG Filings/FA |